News
Dr. David Stevens is recognized among Castle Connolly's Top Doctors® for San Jose, CA
A San Jose, CA Board Certified physician specializing in Infectious Disease, Dr. David Stevens, is a Castle Connolly Top Doctor.
San Jose, CA (PR Newswire) November 20, 2012 - Castle Connolly Medical Ltd., America's trusted source for identifying Top Doctors, has selected San Jose's Infectious Disease specialist Dr. David Stevens for inclusion in its highly selective list of Regional Top Doctors.
Castle Connolly Medical Ltd. publishes its list of Castle Connolly Top Doctors® at castleconnolly.com, as well as in a wide variety of printed directories, partner publications and on partner/affiliate websites including US News and World Report's annually updated list of "Top Doctors." All told, fewer than 35,000 physicians - less than 5% of the nation's licensed physicians - have been selected as Castle Connolly Top Doctors in their regions for their specialties. Read more
CIMR Grant for AIDS Research
The California Institute for Medical Research announces a grant in aid of research on AIDS to Dr. Michele Tang. The funding for this award came from the Burt W. and Virginia Polin Charitable Gift Fund, and was designated for AIDS research. Dr. Tang's application was entitled "Developing a model of asymptomatic and reactivated cryptococcal disease in AIDS". The Cryptococcus is an opportunistic microbe that also infects healthy persons, and is particularly devastating when infecting persons whose immunity is impaired by diseases such as AIDS or a malignancy, or who receive immune suppressive drugs, such as steroids, for a variety of illnesses. It causes over 600,000 deaths globally every year. Her work will contribute to improving defenses against these infections. Click here for complete
Press Release - AIDS Research Grant Awarded
Baker’s yeast protects against fatal infections
Injecting mice with simple baker’s yeast protects against the fatal fungal infection, aspergillosis, according to research published in the Journal of Medical Microbiology. The work could lead to the development of a human vaccine that protects immunocompromised people against a range of life-threatening fungal infections, for which current therapy often fails.
Researchers from the California Institute for Medical Research, Santa Clara Valley Medical Center and Stanford University gave mice three injections of killed Saccharomyces (baker’s yeast), one week apart. Vaccinated mice were able to survive high doses of Aspergillus – the fungus that causes aspergillosis. Mice that survived also showed a reduced infection load in their organs.
The California Institute for Medical Research (CIMR), San Jose is pleased to announce the award of a grant from Gilead Sciences to support an international team of researchers, to develop a new therapy for a parasitic disease of the Americas. The disease is caused by the parasite Trypanosoma cruzi, and is also known as “Chagas’ disease” (for its Brazilian discoverer, over 100 years ago). The disease principally affects the blood, heart and gastrointestinal tract, and is carried by a biting insect. It is estimated 14-16 million people are currently infected worldwide, mostly in Latin America, although there are 300,000 persons infected in the USA. Current treatments are prolonged, toxic and incompletely effective.
